Cargando…

Theabrownin inhibits obesity and non-alcoholic fatty liver disease in mice via serotonin-related signaling pathways and gut-liver axis

INTRODUCTION: Non-alcoholic fatty liver disease (NAFLD) with obesity seriously threats public health. Our previous studies showed that dark tea had more potential on regulating lipid metabolism than other teas, and theabrownin (TB) was considered to be a main contributor to the bioactivity of dark t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Hang-Yu, Huang, Si-Yu, Zhou, Dan-Dan, Xiong, Ruo-Gu, Luo, Min, Saimaiti, Adila, Han, Mu-Ke, Gan, Ren-You, Zhu, Hui-Lian, Li, Hua-Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555776/ https://www.ncbi.nlm.nih.gov/pubmed/36639024 http://dx.doi.org/10.1016/j.jare.2023.01.008

Ejemplares similares

Anti-Obesity Effect of Theabrownin from Dark Tea in C57BL/6J Mice Fed a High-Fat Diet by Metabolic Profiles through Gut Microbiota Using Untargeted Metabolomics
por: Li, Hang-Yu, et al.
Publicado: (2022)

Effects of Different Green Teas on Obesity and Non-Alcoholic Fatty Liver Disease Induced by a High-Fat Diet in Mice
por: Zhou, Dan-Dan, et al.
Publicado: (2022)

Effects of Different Green Tea Extracts on Chronic Alcohol Induced-Fatty Liver Disease by Ameliorating Oxidative Stress and Inflammation in Mice
por: Li, Bang-Yan, et al.
Publicado: (2021)

Effects of Tea against Alcoholic Fatty Liver Disease by Modulating Gut Microbiota in Chronic Alcohol-Exposed Mice
por: Li, Bangyan, et al.
Publicado: (2021)

Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver
por: Ko, Masayoshi, et al.
Publicado: (2021)

Correction: Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver
por: Ko, Masayoshi, et al.
Publicado: (2023)

Preventive Effects of Different Black and Dark Teas on Obesity and Non-Alcoholic Fatty Liver Disease and Modulate Gut Microbiota in High-Fat Diet Fed Mice
por: Li, Bangyan, et al.
Publicado: (2022)

Gut–Liver Axis Derangement in Non-Alcoholic Fatty Liver Disease
por: Poeta, Marco, et al.
Publicado: (2017)

Health Benefits and Side Effects of Short-Chain Fatty Acids
por: Xiong, Ruo-Gu, et al.
Publicado: (2022)

The Role of Gut Microbiota in Anxiety, Depression, and Other Mental Disorders as Well as the Protective Effects of Dietary Components
por: Xiong, Ruo-Gu, et al.
Publicado: (2023)

Fermentation with Tea Residues Enhances Antioxidant Activities and Polyphenol Contents in Kombucha Beverages
por: Zhou, Dan-Dan, et al.
Publicado: (2022)

Naturally Occurring Stilbenoid TSG Reverses Non-Alcoholic Fatty Liver Diseases via Gut-Liver Axis
por: Lin, Pei, et al.
Publicado: (2015)

The Gut-Liver Axis in Nonalcoholic Fatty Liver Disease: Association of Intestinal Permeability with Disease Severity and Treatment Outcomes
por: Zhuang, Yu-Pei, et al.
Publicado: (2022)

Gut–Liver Axis and Non-Alcoholic Fatty Liver Disease: A Vicious Circle of Dysfunctions Orchestrated by the Gut Microbiome
por: Pezzino, Salvatore, et al.
Publicado: (2022)

Possible Effects and Mechanisms of Dietary Natural Products and Nutrients on Depression and Anxiety: A Narrative Review
por: Wu, Si-Xia, et al.
Publicado: (2022)

Amelioratory Effect of Resistant Starch on Non-alcoholic Fatty Liver Disease via the Gut-Liver Axis
por: Zhu, Weifeng, et al.
Publicado: (2022)

Gut-liver axis modulation of Panax notoginseng saponins in nonalcoholic fatty liver disease
por: Xu, Yu, et al.
Publicado: (2021)

Antioxidant Capacities and Polyphenol Contents of Kombucha Beverages Based on Vine Tea and Sweet Tea
por: Saimaiti, Adila, et al.
Publicado: (2022)

Chinese Medicinal Herbs Targeting the Gut–Liver Axis and Adipose Tissue–Liver Axis for Non-Alcoholic Fatty Liver Disease Treatments: The Ancient Wisdom and Modern Science
por: Zhang, Shuwei, et al.
Publicado: (2020)

Distinctive gut microbial dysbiosis between chronic alcoholic fatty liver disease and metabolic-associated fatty liver disease in mice
por: Kang, Kai, et al.
Publicado: (2021)

Effects and Mechanisms of Resveratrol on Aging and Age-Related Diseases
por: Zhou, Dan-Dan, et al.
Publicado: (2021)

Antioxidant Activities, Phenolic Compounds, and Sensory Acceptability of Kombucha-Fermented Beverages from Bamboo Leaf and Mulberry Leaf
por: Xiong, Ruo-Gu, et al.
Publicado: (2023)

Role of serotonin in fatty acid-induced non-alcoholic fatty liver disease in mice
por: Ritze, Yvonne, et al.
Publicado: (2013)

“Liver–gut” axis: A target of traditional Chinese medicine for the treatment of non-alcoholic fatty liver disease
por: Guo, Kangxiao, et al.
Publicado: (2022)

The Role of Gut Microbiota-Bile Acids Axis in the Progression of Non-alcoholic Fatty Liver Disease
por: Ni, Yiming, et al.
Publicado: (2022)

Serotonin signals through a gut-liver axis to regulate hepatic steatosis
por: Choi, Wonsuk, et al.
Publicado: (2018)

Preparation, Antioxidant Activities and Bioactive Components of Kombucha Beverages from Golden-Flower Tea (Camellia petelotii) and Honeysuckle-Flower Tea (Lonicera japonica)
por: Wu, Si-Xia, et al.
Publicado: (2023)

Understanding gut-liver axis nitrogen metabolism in Fatty Liver Disease
por: Delgado, Teresa C., et al.
Publicado: (2022)

Theabrownin and Poria cocos Polysaccharide Improve Lipid Metabolism via Modulation of Bile Acid and Fatty Acid Metabolism
por: Wang, Jieyi, et al.
Publicado: (2022)

Non-alcoholic fatty liver and the gut microbiota
por: Bashiardes, Stavros, et al.
Publicado: (2016)

Partially hydrolyzed guar gum attenuates non-alcoholic fatty liver disease in mice through the gut-liver axis
por: Takayama, Shun, et al.
Publicado: (2021)

Research Progress on the Therapeutic Effect of Polysaccharides on Non-Alcoholic Fatty Liver Disease through the Regulation of the Gut–Liver Axis
por: Chen, Xiang, et al.
Publicado: (2022)

Diet, Gut Microbiota and Non-Alcoholic Fatty Liver Disease: Three Parts of the Same Axis
por: Quesada-Vázquez, Sergio, et al.
Publicado: (2020)

Intervention of Shugan Xiaozhi Decoction on Nonalcoholic Fatty Liver Disease via Mediating Gut-Liver Axis
por: Yang, Huili, et al.
Publicado: (2022)

Contrasting Effects of Fasting on Liver-Adipose Axis in Alcohol-Associated and Non-alcoholic Fatty Liver
por: Rasineni, Karuna, et al.
Publicado: (2021)

Anti-Adipogenic Effect of Theabrownin Is Mediated by Bile Acid Alternative Synthesis via Gut Microbiota Remodeling
por: Kuang, Junliang, et al.
Publicado: (2020)

The Role of the Gut-Liver Axis in Metabolic Dysfunction-Associated Fatty Liver Disease
por: Martín-Mateos, Rosa, et al.
Publicado: (2021)

Bile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease
por: Xue, Rui, et al.
Publicado: (2021)

The role of microbiome in the pathogenesis of oral-gut-liver axis between periodontitis and nonalcoholic fatty liver disease
por: Chen, Tsung-Po, et al.
Publicado: (2023)

Bioactive Compounds, Health Benefits and Food Applications of Grape
por: Zhou, Dan-Dan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_th2bbegcdncc5g5qeo1is4nd0b